In the cell proliferation experiment, compared with the serum of HCC mice at 48 and 72 h, the serum of SD-HCC mice promoted the proliferation of HCC cells and the addition of CTLA-4 inhibitor could partially reverse this change. This evidence concerns the gene CTLA4 and hepatocellular carcinoma.